SCOPUS 정보 검색 플랫폼

American Journal of Clinical Pathology

Volumn 137, Issue 6, 2012, Pages 918-930

A search for reliable molecular markers of prognosis in prostate cancer: A study of 240 cases

(6) Tradonsky, Alison a Rubin, Tammy a Beck, Rodney b Ring, Brian b Seitz, Robert b Mair, Sharon a

a SHARP GROSSMONT HOSPITAL (United States)

b Clarient ^* (United States)

Author keywords

CDH1 E cadherin; CYP4Z1 cytochrome p450 4z1; Hey2; Immunostains; Prognostic markers; Prostate cancer; STMN1 stathmin 1

Indexed keywords

CYTOCHROME P450 4Z1; HEY2 PROTEIN; PROSTATE SPECIFIC ANTIGEN; STATHMIN 1; TUMOR MARKER; UNCLASSIFIED DRUG; UVOMORULIN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; BIOLOGICAL MARKER; CADHERIN; CDH1 PROTEIN, HUMAN; CYP4Z1 PROTEIN, HUMAN; CYTOCHROME P450; HEY2 PROTEIN, HUMAN; REPRESSOR PROTEIN; STATHMIN; STMN1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PROGNOSIS; FOLLOW UP; GENE SEQUENCE; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; TISSUE MICROARRAY; TREATMENT OUTCOME; CANCER GRADING; CLASSIFICATION; COHORT ANALYSIS; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSTATE; PROSTATE TUMOR;

AGED; AGED, 80 AND OVER; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BIOLOGICAL MARKERS; CADHERINS; COHORT STUDIES; CYTOCHROME P-450 ENZYME SYSTEM; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; REPRESSOR PROTEINS; RETROSPECTIVE STUDIES; STATHMIN; TISSUE ARRAY ANALYSIS; TREATMENT OUTCOME;

EID: 84863756568 PISSN: 00029173 EISSN: 19437722 Source Type: Journal
DOI: 10.1309/AJCPF3QWIG8FWXIH Document Type: Article

Times cited : (39)

References (35)

1
- 77955635233
- Cancer statistics
- Jermal A, Siegal R, Xu J, et al. Cancer statistics. CA Cancer J Clin. 2010;60:277-300.
- (2010) CA Cancer J Clin , vol.60 , pp. 277-300
- Jermal, A.¹ Siegal, R.² Xu, J.³

2
- 61349162225
- Prostate biopsy: Current status and limitations
- Presti JC Jr. Prostate biopsy: current status and limitations. Rev Urol. 2007;9:93-98.
- (2007) Rev Urol , vol.9 , pp. 93-98
- Presti Jr., J.C.¹

3
- 80051931834
- Molecular predictor of metastatic cancer identified
- Printz C. Molecular predictor of metastatic cancer identified. Cancer. 2011;117:2829.
- (2011) Cancer , vol.117 , pp. 2829
- Printz, C.¹

4
- 77949363162
- American Cancer Society guideline for the early detection of prostate cancer: Update 2010
- Wolf AMD, Wender RC, Etzioni RB, et al. American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin. 2010;60:70-98.
- (2010) CA Cancer J Clin , vol.60 , pp. 70-98
- Wolf, A.M.D.¹ Wender, R.C.² Etzioni, R.B.³

5
- 11144240494
- Molecular markers and prostate cancer prognosis
- Chin JL, Reiter RE. Molecular markers and prostate cancer prognosis. Clin Prostate Cancer. 2004;3:157-164. (Pubitemid 40051707)
- (2004) Clinical Prostate Cancer , vol.3 , Issue.3 , pp. 157-164
- Chin, J.L.¹ Reiter, R.E.²

6
- 4043109265
- Prognostic factors in prostate cancer
- Ross JS, Jennings TA, Nazeer T, et al. Prognostic factors in prostate cancer. Am J Clin Pathol. 2003;120(suppl 1):S85-S100.
- (2003) Am J Clin Pathol , vol.120 , Issue.SUPPL. 1
- Ross, J.S.¹ Jennings, T.A.² Nazeer, T.³

7
- 34247591993
- Multiple prostate cancer risk variants on 8q24
- DOI 10.1038/ng0507-579, PII NG0507579
- Witte JS. Multiple prostate cancer risk variants on 8q24. Nat Genet. 2007;39:579-580. (Pubitemid 46676095)
- (2007) Nature Genetics , vol.39 , Issue.5 , pp. 579-580
- Witte, J.S.¹

9
- 34247482327
- Multiple regions within 8q24 independently affect risk for prostate cancer
- DOI 10.1038/ng2015, PII NG2015
- Haiman CA, Patterson N, Freedman ML, et al. Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet. 2007;39:638-644. (Pubitemid 46676106)
- (2007) Nature Genetics , vol.39 , Issue.5 , pp. 638-644
- Haiman, C.A.¹ Patterson, N.² Freedman, M.L.³ Myers, S.R.⁴ Pike, M.C.⁵ Waliszewska, A.⁶ Neubauer, J.⁷ Tandon, A.⁸ Schirmer, C.⁹ McDonald, G.J.¹⁰ Greenway, S.C.¹¹ Stram, D.O.¹² Le, M.L.¹³ Kolonel, L.N.¹⁴ Frasco, M.¹⁵ Wong, D.¹⁶ Pooler, L.C.¹⁷ Ardlie, K.¹⁸ Oakley-Girvan, I.¹⁹ Whittemore, A.S.²⁰ more..

10
- 34247548755
- Genome-wide association study of prostate cancer identifies a second risk locus at 8q24
- DOI 10.1038/ng2022, PII NG2022
- Yeager M, Orr N, Hayes RB, et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet. 2007;39:645-649. (Pubitemid 46676108)
- (2007) Nature Genetics , vol.39 , Issue.5 , pp. 645-649
- Yeager, M.¹ Orr, N.² Hayes, R.B.³ Jacobs, K.B.⁴ Kraft, P.⁵ Wacholder, S.⁶ Minichiello, M.J.⁷ Fearnhead, P.⁸ Yu, K.⁹ Chatterjee, N.¹⁰ Wang, Z.¹¹ Welch, R.¹² Staats, B.J.¹³ Calle, E.E.¹⁴ Feigelson, H.S.¹⁵ Thun, M.J.¹⁶ Rodriguez, C.¹⁷ Albanes, D.¹⁸ Virtamo, J.¹⁹ Weinstein, S.²⁰ more..

12
- 38449103390
- Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP
- DOI 10.1093/jnci/djm250
- Duggan D, Zheng SL, Knowlton M, et al. Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB21P. J Natl Cancer Inst. 2007;99:1836-1844. (Pubitemid 351767196)
- (2007) Journal of the National Cancer Institute , vol.99 , Issue.24 , pp. 1836-1844
- Duggan, D.¹ Zheng, S.L.² Knowlton, M.³ Benitez, D.⁴ Dimitrov, L.⁵ Wiklund, F.⁶ Robbins, C.⁷ Isaacs, S.D.⁸ Cheng, Y.⁹ Li, G.¹⁰ Sun, J.¹¹ Chang, B.-L.¹² Marovich, L.¹³ Wiley, K.E.¹⁴ Balter, K.¹⁵ Stattin, P.¹⁶ Adami, H.-O.¹⁷ Gielzak, M.¹⁸ Yan, G.¹⁹ Sauvageot, J.²⁰ more..

16
- 27344451557
- Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
- DOI 10.1126/science.1117679
- Tomlins SA, Rhodes DR, Perner S, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005;310:644-648. (Pubitemid 41528150)
- (2005) Science , vol.310 , Issue.5748 , pp. 644-648
- Tomlins, S.A.¹ Rhodes, D.R.² Perner, S.³ Dhanasekaran, S.M.⁴ Mehra, R.⁵ Sun, X.-W.⁶ Varambally, S.⁷ Cao, X.⁸ Tchinda, J.⁹ Kuefer, R.¹⁰ Lee, C.¹¹ Montie, J.E.¹² Shah, R.B.¹³ Pienta, K.J.¹⁴ Rubin, M.A.¹⁵ Chinnaiyan, A.M.¹⁶

17
- 34547642493
- Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
- DOI 10.1038/nature06024, PII NATURE06024
- Tomlins SA, Laxman B, Dhanasekaran SM, et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature. 2007;448:595-599. (Pubitemid 47206938)
- (2007) Nature , vol.448 , Issue.7153 , pp. 595-599
- Tomlins, S.A.¹ Laxman, B.² Dhanasekaran, S.M.³ Helgeson, B.E.⁴ Cao, X.⁵ Morris, D.S.⁶ Menon, A.⁷ Jing, X.⁸ Cao, Q.⁹ Han, B.¹⁰ Yu, J.¹¹ Wang, L.¹² Montie, J.E.¹³ Rubin, M.A.¹⁴ Pienta, K.J.¹⁵ Roulston, D.¹⁶ Shah, R.B.¹⁷ Varambally, S.¹⁸ Mehra, R.¹⁹ Chinnaiyan, A.M.²⁰ more..

18
- 45849103492
- Recurrent gene fusions in prostate cancer
- Kumar-Sinha C, Tomlins SA, Chinnaiyan AM. Recurrent gene fusions in prostate cancer. Nat Rev Cancer. 2008;8:497-511.
- (2008) Nat Rev Cancer , vol.8 , pp. 497-511
- Kumar-Sinha, C.¹ Tomlins, S.A.² Chinnaiyan, A.M.³

19
- 41049114826
- 8q24 and prostate cancer: Association with advanced disease and meta-analysis
- DOI 10.1038/sj.ejhg.5201959, PII 5201959
- Cheng I, Plummer SJ, Jorgenson E, et al. 8q24 and prostate cancer: association with advanced disease and meta-analysis. Eur J Hum Genet. 2008;16:496-505. (Pubitemid 351420383)
- (2008) European Journal of Human Genetics , vol.16 , Issue.4 , pp. 496-505
- Cheng, I.¹ Plummer, S.J.² Jorgenson, E.³ Liu, X.⁴ Rybicki, B.A.⁵ Casey, G.⁶ Witte, J.S.⁷

20
- 40049098166
- Cumulative association of five genetic variants with prostate cancer
- DOI 10.1056/NEJMoa075819
- Zheng SL, Sun J, Wiklund F, et al. Cumulative association of five genetic variants with prostate cancer. N Engl J Med. 2008;358:910-919. (Pubitemid 351397090)
- (2008) New England Journal of Medicine , vol.358 , Issue.9 , pp. 910-919
- Zheng, S.L.¹ Sun, J.² Wiklund, F.³ Smith, S.⁴ Stattin, P.⁵ Li, G.⁶ Adami, H.-O.⁷ Hsu, F.-C.⁸ Zhu, Y.⁹ Balter, K.¹⁰ Kader, A.K.¹¹ Turner, A.R.¹² Liu, W.¹³ Bleecker, E.R.¹⁴ Meyers, D.A.¹⁵ Duggan, D.¹⁶ Carpten, J.D.¹⁷ Chang, B.-L.¹⁸ Isaacs, W.B.¹⁹ Xu, J.²⁰ Gronberg, H.²¹ more..

21
- 37049015104
- Expression of the TMPRSS2: ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer
- DOI 10.1038/sj.bjc.6604054, PII 6604054
- Nam RK, Sugar L, Yang W, et al. Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer. Br J Cancer. 2007;97:1690-1695. (Pubitemid 350249347)
- (2007) British Journal of Cancer , vol.97 , Issue.12 , pp. 1690-1695
- Nam, R.K.¹ Sugar, L.² Yang, W.³ Srivastava, S.⁴ Klotz, L.H.⁵ Yang, L.-Y.⁶ Stanimirovic, A.⁷ Encioiu, E.⁸ Neill, M.⁹ Loblaw, D.A.¹⁰ Trachtenberg, J.¹¹ Narod, S.A.¹² Seth, A.¹³

22
- 34447342868
- TMPRSS2-ERG fusion prostate cancer: An early molecular event associated with invasion
- DOI 10.1097/01.pas.0000213424.38503.aa, PII 0000047820070600000008
- Perner S, Mosquera JM, Demichelis F, et al. TMPSS2-EGR fusion prostate cancer: an early molecular event associated with invasion. Am J Surg Pathol. 2007;31:882-888. (Pubitemid 47165141)
- (2007) American Journal of Surgical Pathology , vol.31 , Issue.6 , pp. 882-888
- Perner, S.¹ Mosquera, J.-M.² Demichelis, F.³ Hofer, M.D.⁴ Paris, P.L.⁵ Simko, J.⁶ Collins, C.⁷ Bismar, T.A.⁸ Chinnaiyan, A.M.⁹ De Marzo, A.M.¹⁰ Rubin, M.A.¹¹

23
- 57149118933
- Emerging biomarkers for the diagnosis and prognosis of prostate cancer
- DOI 10.1373/clinchem.2008.110668
- Girish S, Dowell B, Diamandi, EP. Emerging biomarkers for the diagnosis and prognosis of prostate cancer. Clin Chem. 2008;54:1951-1960. (Pubitemid 352774027)
- (2008) Clinical Chemistry , vol.54 , Issue.12 , pp. 1951-1960
- Sardana, G.¹ Dowell, B.² Diamandis, E.P.³

24
- 76749091149
- Low levels of phosphorylated epidermal growth factor receptor in nonmalignant and malignant prostate tissue predict favorable outcome in prostate cancer patients
- Hammarsten P, Karalija A, Josefsson A, et al. Low levels of phosphorylated epidermal growth factor receptor in nonmalignant and malignant prostate tissue predict favorable outcome in prostate cancer patients. Clin Cancer Res. 2010;16:1245-1255.
- (2010) Clin Cancer Res , vol.16 , pp. 1245-1255
- Hammarsten, P.¹ Karalija, A.² Josefsson, A.³

25
- 65349183478
- Regulation of prostate cancer progression by galectin-3
- Wang Y, Nangia-Makker P, Tait L, et al. Regulation of prostate cancer progression by galectin-3. Am J Pathol. 2009;174:1515-1523.
- (2009) Am J Pathol , vol.174 , pp. 1515-1523
- Wang, Y.¹ Nangia-Makker, P.² Tait, L.³

26
- 48749088691
- KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis
- Narla G, DiFeo A, Fernandez Y, et al. KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis. J Clin Invest. 2008;118:2711-2721.
- (2008) J Clin Invest , vol.118 , pp. 2711-2721
- Narla, G.¹ DiFeo, A.² Fernandez, Y.³

27
- 84864198793
- Characterization of KRAS rearrangements in metastatic prostate cancer
- [published online ahead of print April 3, 2011]. doi:10.1158/2159-8274. CD-10-0022
- Xiao-Song W, Shankar S, Saravana MD, et al. Characterization of KRAS rearrangements in metastatic prostate cancer [published online ahead of print April 3, 2011]. Cancer Discovery. 2011;1:35-43. doi:10.1158/2159-8274.CD-10- 0022.
- (2011) Cancer Discovery , vol.1 , pp. 35-43
- Xiao-Song, W.¹ Shankar, S.² Saravana, M.D.³

28
- 11144240494
- Molecular markers and prostate cancer prognosis
- Chin JL, Reiter RE. Molecular markers of prostate cancer prognosis. Clin Prostate Cancer. 2004;3:157-164. (Pubitemid 40051707)
- (2004) Clinical Prostate Cancer , vol.3 , Issue.3 , pp. 157-164
- Chin, J.L.¹ Reiter, R.E.²

29
- 79951497419
- The genomic complexity of primary human prostate cancer
- Berger MF, Lawrence MS, Demichelis F, et al. The genomic complexity of primary human prostate cancer. Nature. 2011;470:214-220.
- (2011) Nature , vol.470 , pp. 214-220
- Berger, M.F.¹ Lawrence, M.S.² Demichelis, F.³

30
- 79951512852
- SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
- Ding Z, Wu CJ, Chu GC, et al. SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature. 2011;470:269-273.
- (2011) Nature , vol.470 , pp. 269-273
- Ding, Z.¹ Wu, C.J.² Chu, G.C.³

31
- 78650606864
- Novel diagnostic biomarkers for prostate cancer
- Madu CO, Lu Y. Novel diagnostic biomarkers for prostate cancer. J Cancer. 2010;1:150-177.
- (2010) J Cancer , vol.1 , pp. 150-177
- Madu, C.O.¹ Lu, Y.²

32
- 33747065800
- Cancer biomarkers: A systems approach
- Hartwell l, Mankoff D, Paulovich A. et al. Cancer biomarkers: a systems approach. Nat Biotechnol. 2006;24:905-908.
- (2006) Nat Biotechnol , vol.24 , pp. 905-908
- Hartwell, L.¹ Mankoff, D.² Paulovich, A.³

33
- 0344456745
- 7th ed. New York, NY: Springer-Verlag
- Edge SB, Byrd DR, Compton CC, et al, eds. AJCC Staging Manual. 7th ed. New York, NY: Springer-Verlag; 2009.
- (2009) AJCC Staging Manual
- Edge, S.B.¹ Byrd, D.R.² Compton, C.C.³

34
- 33746006844
- Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer
- DOI 10.1200/JCO.2006.05.6564
- Ring BZ, Seitz RS, Beck RA, et al. Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer. J Clin Oncol. 2006;24:3039-3047. (Pubitemid 46638938)
- (2006) Journal of Clinical Oncology , vol.24 , Issue.19 , pp. 3039-3047
- Ring, B.Z.¹ Seitz, R.S.² Beck, R.³ Shasteen, W.J.⁴ Tarr, S.M.⁵ Cheang, M.C.U.⁶ Yoder, B.J.⁷ Budd, G.T.⁸ Nielsen, T.O.⁹ Hicks, D.G.¹⁰ Estopinal, N.C.¹¹ Ross, D.T.¹²

35
- 58149183234
- Chemosensitivity and stratification by a five monoclonal antibody immunohistochemistry test in the NSABP B14 and B20 trials
- Ross DT, Kim CY, Tang G, et al. Chemosensitivity and stratification by a five monoclonal antibody immunohistochemistry test in the NSABP B14 and B20 trials. Clin Cancer Res. 2008;14:6602-6609.
- (2008) Clin Cancer Res , vol.14 , pp. 6602-6609
- Ross, D.T.¹ Kim, C.Y.² Tang, G.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.